אתר זה משתמש בעוגיות (Cookies) לשיפור חווית הגלישה.
לקריאת הצהרת הפרטיות שלנו.
Dr. Peter J. Fitzgerald
Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University Medical School.
A professor in both the Departments of Medicine and Engineering at Stanford.
He has led or participated in over 150 clinical trials, published over 450 manuscripts/chapters, and lectures worldwide. He has trained over 150 post-docs in Engineering and Medicine in the past decade.In addition, he heads the Stanford/Asia MedTech innovation program
Fitzgerald has been principle/founder of 18 medical device companies in the San Francisco Bay Area. He has transitioned twelve of these start-ups to large medical device companies. He serves on several boards of directors, advised dozens of medical device startups as well as multinational healthcare companies in the design and development of new diagnostic and therapeutic devices in the cardiovascular arena.
Was part of the founding team of LVP Capital, a venture firm, focused on medical device and biotechnology start-ups in San Francisco, and co-founded TriVentures, which is an incubator/venture fund for early stage medical technology in Israel.
Interventional Cardiologist and has a PhD in Engineering